Sonoma Pharmaceuticals Announces Fiscal First Quarter 2018 Financial Results and Conference Call
July 25 2017 - 4:05AM
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA, warrants SNOAW), today
announced that the financial results for its fiscal first quarter
2018, ended June 30, 2017, will be released after the U.S. markets
close on August 8, 2017. The earnings release will be
followed by a conference call at 1:30 p.m. PDT on August 8, 2017,
to discuss fiscal first quarter results.
Individuals interested in participating in the conference call
may do so by dialing 877-303-7607 for domestic callers or
973-638-3203 for international callers. Those interested in
listening to the conference call live via the internet may do so at
http://ir.sonomapharma.com/events.cfm.
A telephone replay will be available for seven days following
the conclusion of the call by dialing 855-859-2056 for domestic
callers, or 404-537-3406 for international callers, and entering
conference code 47563590. A webcast replay will be available on the
site at http://ir.sonomapharma.com/events.cfm for one year
following the call.
About Sonoma Pharmaceuticals, Inc.Sonoma
Pharmaceuticals (formerly Oculus Innovative Sciences) is a
specialty pharmaceutical company that develops and
markets solutions for the treatment of dermatological
conditions and advanced tissue care. The company’s
products, which are sold throughout the United States and
internationally, have improved outcomes for more than five million
patients globally by reducing infections, itch, pain, scarring
and harmful inflammatory responses. The company's headquarters are
in Petaluma, California, with manufacturing operations in the
United States and Latin America. European marketing and sales
are headquartered in Roermond, Netherlands. More information can be
found at www.sonomapharma.com.
Media and Investor Contact:
Sonoma Pharmaceuticals, Inc.
Dan McFadden
VP of Public and Investor Relations
(425) 753-2105
dmcfadden@sonomapharma.com
Sonoma Pharmaceuticals (NASDAQ:SNOAW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sonoma Pharmaceuticals (NASDAQ:SNOAW)
Historical Stock Chart
From Apr 2023 to Apr 2024